NFKB1 and colorectal cancer: In colorectal cancer, they show an antitumorigenic and anti-inflammatory effect via NF-κB, Nrf2, Wnt, and β-catenin pathways modulation [55,56,57] and induce cytotoxicity in HT-29 colorectal cancer cells in a dose-dependent manner [58].